Variant report

Variant	rs547956879
Chromosome Location	chr11:47968002-47968003
allele	C/T
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:0)
CpG islands
(count:0)
Chromatin interactive
region (count:7)
LncRNA
region (count:1)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

No data

(count:7 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr11:47967425..47969925-chr11:48129768..48132712,2	MCF-7	breast:
2	chr11:47964794..47968609-chr11:48000698..48003518,3	MCF-7	breast:
3	chr11:47967526..47970354-chr11:47971440..47973088,2	K562	blood:
4	chr11:47964249..47967260-chr11:47967441..47970649,3	K562	blood:
5	chr11:47967015..47968589-chr11:48075080..48077424,2	MCF-7	breast:
6	chr11:47967043..47970395-chr11:47999984..48003579,8	MCF-7	breast:
7	chr11:47967141..47970110-chr11:47980010..47981597,2	MCF-7	breast:

(count:1 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-PTPRJ-1	chr11:47967903-47968054	NONHSAT021290

No data

Variant related genes	Relation type
ENSG00000149177	Chromatin interaction

Extended variants
information (count: 10 )
Associated
traits (count: 0)

Variant overlapped rSNPs/rCNVs (count:10 , 50 per page) page: 1

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	nsv1052397	chr11:47675470-48594256	Weak transcription Strong transcription Genic enhancers Enhancers Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS ZNF genes & repeats Bivalent/Poised TSS Transcr. at gene 5' and 3' Bivalent Enhancer	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	97 gene(s)	inside rSNPs	diseases
2	nsv530620	chr11:47765455-48664555	Weak transcription Genic enhancers Enhancers Flanking Active TSS Strong transcription Active TSS ZNF genes & repeats Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Bivalent/Poised TSS Bivalent Enhancer	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	93 gene(s)	inside rSNPs	diseases
3	nsv1036992	chr11:47794621-48666024	Strong transcription Flanking Active TSS Enhancers Weak transcription Active TSS Transcr. at gene 5' and 3' ZNF genes & repeats Genic enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	54 gene(s)	inside rSNPs	diseases
4	nsv897326	chr11:47891334-48035474	Flanking Bivalent TSS/Enh Enhancers Weak transcription Flanking Active TSS Bivalent/Poised TSS ZNF genes & repeats Bivalent Enhancer Genic enhancers Active TSS Strong transcription Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA	5 gene(s)	inside rSNPs	diseases
5	nsv1036451	chr11:47902321-48616646	Weak transcription Enhancers ZNF genes & repeats Strong transcription Genic enhancers Flanking Active TSS Active TSS Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Bivalent/Poised TSS Bivalent Enhancer	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	26 gene(s)	inside rSNPs	diseases
6	nsv541037	chr11:47902321-48616646	Enhancers Strong transcription Genic enhancers Flanking Active TSS Weak transcription ZNF genes & repeats Active TSS Bivalent/Poised TSS Bivalent Enhancer Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	26 gene(s)	inside rSNPs	diseases
7	nsv1047490	chr11:47916708-48388686	Enhancers Weak transcription Flanking Active TSS Strong transcription Bivalent/Poised TSS Active TSS Genic enhancers ZNF genes & repeats Flanking Bivalent TSS/Enh Bivalent Enhancer Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	15 gene(s)	inside rSNPs	diseases
8	nsv1044266	chr11:47929586-48276132	Weak transcription ZNF genes & repeats Enhancers Flanking Active TSS Strong transcription Genic enhancers Active TSS Bivalent Enhancer Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	10 gene(s)	inside rSNPs	diseases
9	nsv541038	chr11:47929586-48276132	Weak transcription Enhancers ZNF genes & repeats Strong transcription Genic enhancers Flanking Active TSS Active TSS Bivalent Enhancer Bivalent/Poised TSS Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	10 gene(s)	inside rSNPs	diseases
10	nsv1053145	chr11:47967902-48086950	Enhancers Flanking Bivalent TSS/Enh Weak transcription Bivalent Enhancer Flanking Active TSS Active TSS Strong transcription Genic enhancers Transcr. at gene 5' and 3' Bivalent/Poised TSS ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA	3 gene(s)	inside rSNPs	diseases

No data

Chromatin state (count:62 , 50 per page) page: 1 2

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr11:47950800-47971800	Weak transcription	Fetal Thymus	thymus
2	chr11:47954400-47968200	Weak transcription	Skeletal Muscle Female	skeletal muscle
3	chr11:47956800-47970200	Weak transcription	Primary T helper cells fromperipheralblood	blood
4	chr11:47959800-47968800	Weak transcription	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
5	chr11:47960000-47972400	Weak transcription	Lung	lung
6	chr11:47964000-47968400	Weak transcription	Primary B cells from peripheral blood	blood
7	chr11:47964000-47968400	Weak transcription	GM12878-XiMat	blood
8	chr11:47964000-47972200	Weak transcription	Primary mononuclear cells fromperipheralblood	Blood
9	chr11:47964200-47968400	Weak transcription	Placenta	Placenta
10	chr11:47964400-47968800	Weak transcription	Right Atrium	heart
11	chr11:47964600-47968600	Weak transcription	Liver	Liver
12	chr11:47966000-47968200	Enhancers	Primary neutrophils fromperipheralblood	blood
13	chr11:47966200-47968600	Weak transcription	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
14	chr11:47966200-47968600	Weak transcription	H9 Cell Line	embryonic stem cell
15	chr11:47966200-47968600	Weak transcription	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
16	chr11:47966200-47968600	Weak transcription	IMR90 fetal lung fibroblasts Cell Line	lung
17	chr11:47966200-47969800	Weak transcription	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
18	chr11:47966200-47972200	Weak transcription	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
19	chr11:47966400-47968200	Weak transcription	ES-WA7 Cell Line	embryonic stem cell
20	chr11:47966400-47968200	Weak transcription	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
21	chr11:47966400-47968200	Weak transcription	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
22	chr11:47966400-47968200	Weak transcription	NHDF-Ad	bronchial
23	chr11:47966400-47968600	Weak transcription	NHLF	lung
24	chr11:47966400-47969000	Enhancers	ES-I3 Cell Line	embryonic stem cell
25	chr11:47966400-47969200	Enhancers	HUES48 Cell Line	embryonic stem cell
26	chr11:47966600-47968200	Weak transcription	HUES6 Cell Line	embryonic stem cell
27	chr11:47966600-47968200	Weak transcription	iPS-15b Cell Line	embryonic stem cell
28	chr11:47966600-47968200	Weak transcription	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
29	chr11:47966600-47968200	Weak transcription	Muscle Satellite Cultured Cells	--
30	chr11:47966600-47968200	Weak transcription	HSMM	muscle
31	chr11:47966600-47968200	Weak transcription	HUVEC	blood vessel
32	chr11:47966600-47968200	Enhancers	K562	blood
33	chr11:47966600-47968200	Weak transcription	Osteobl	bone
34	chr11:47966600-47968400	Weak transcription	HUES64 Cell Line	embryonic stem cell
35	chr11:47966600-47968400	Weak transcription	iPS-18 Cell Line	embryonic stem cell
36	chr11:47966600-47968600	Weak transcription	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
37	chr11:47966600-47972000	Weak transcription	Dnd41	blood
38	chr11:47966800-47968600	Weak transcription	H1 Cell Line	embryonic stem cell
39	chr11:47966800-47968600	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
40	chr11:47966800-47970000	Enhancers	H1 Derived Mesenchymal Stem Cells	ES cell derived
41	chr11:47967000-47968200	Weak transcription	iPS-20b Cell Line	embryonic stem cell
42	chr11:47967200-47968600	Weak transcription	ES-UCSF4 Cell Line	embryonic stem cell
43	chr11:47967200-47971000	Enhancers	Foreskin Keratinocyte Primary Cells skin02	Skin
44	chr11:47967400-47968200	Enhancers	Monocytes-CD14+_RO01746	blood
45	chr11:47967400-47969400	Enhancers	Foreskin Keratinocyte Primary Cells skin03	Skin
46	chr11:47967400-47973200	Enhancers	Primary B cells from cord blood	blood
47	chr11:47967400-47974000	Enhancers	Primary monocytes fromperipheralblood	blood
48	chr11:47967600-47969200	Enhancers	Primary T helper cells PMA-I stimulated	--
49	chr11:47967600-47969400	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Female	--
50	chr11:47967600-47971400	Enhancers	Primary hematopoietic stem cells short term culture	blood

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links